While I appreciate the honesty, there are a lot of assumptions being made.
In DT’s words, he chose to step down for the benefit of shareholders, at the same time feels confident in the current management to continue with the next phase of commercialisation for RAC.
Damian is quite appreciative of DT for laying the clinical foundation, and everything else.
Many longs here can confirm, to what extent DT go to get the best deal for shareholders for a mining company. So, you can use that as a guide to what he would do for a company where he has a significant investment. Yes, Buyout seems only way out for him without destroying the market cap.
There are many factors that can rise the SP in short to medium term- Partnership news with BP, clinical results along with FTO data, any biotech fund taking position, or simply a sound strategy by the company to materialise the content of triangle report conservative figure ($5-$8B) per year on 5% population. That’s only for breast cancer.
Any doubts, feel free to contact the company.
General Comments / Chat, page-7573
-
- There are more pages in this discussion • 3,533 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.88 |
Change
0.115(6.52%) |
Mkt cap ! $312.5M |
Open | High | Low | Value | Volume |
$1.78 | $1.91 | $1.78 | $434.2K | 234.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 355 | $1.87 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.90 | 4393 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 6752 | 1.865 |
3 | 2432 | 1.860 |
3 | 6900 | 1.855 |
3 | 56100 | 1.850 |
2 | 496 | 1.845 |
Price($) | Vol. | No. |
---|---|---|
1.900 | 4393 | 1 |
1.905 | 550 | 1 |
1.925 | 7649 | 1 |
1.930 | 13777 | 2 |
1.950 | 8000 | 1 |
Last trade - 12.53pm 11/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |